Korea 2023 Review: R&D Potential Shines Through Despite Challenges

ADCs, TPD Come Into Focus

 
• By Jung Won Shin
  
2023 Scrip Perspectives
Despite a challenging dealmaking and financing environment, Korean firms focused on finding new growth engines • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Focus On Asia